Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.
de Keizer B, van Aken MO, Feelders RA, de Herder WW, Kam BL, van Essen M, Krenning EP, Kwekkeboom DJ.
Eur J Nucl Med Mol Imaging. 2008 Apr; 35(4):749-55. Epub 2008 Jan 16.
[Eur J Nucl Med Mol Imaging. 2008]